NCT03771638View on ClinicalTrials.gov

DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

April 21, 2020

Study Completion Date

April 21, 2020

Conditions
Adherence, MedicationRisk BehaviorPre-Exposure ProphylaxisHIV Prevention
Interventions
DRUG

Emtricitabine / Tenofovir Disoproxil Oral Tablet

Open label daily emtricitabine/tenofovir disoproxil oral tablet

OTHER

DOT Diary mobile app

DOT Diary mobile application for tracking medication adherence and sexual activities.

Trial Locations (2)

30322

Emory University, School of Public Health, Atlanta

94102

Bridge HIV, San Francisco Department of Public Health, San Francisco

Sponsors

Collaborators (1)

AiCure
All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

San Francisco Department of Public Health

OTHER_GOV

collaborator

Emory University

OTHER

collaborator

AiCure

INDUSTRY

lead

Public Health Foundation Enterprises, Inc.

OTHER

NCT03771638 - DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men | Biotech Hunter | Biotech Hunter